Mark A. Gohr
Directeur Financier/CFO chez ANTH1, Inc.
Provenance du réseau au premier degré de Mark A. Gohr
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
ANTH1, Inc.
 ANTH1, Inc. Pharmaceuticals: MajorHealth Technology ANTH1, Inc. operates as a development stage company. It is a biotechnology company dedicated to developing vaccines for several infectious diseases including H5N1 influenza virus. The firm utilizes state of the art recombinant DNA adenoviral vector and Rnai (inhibition RNA) technologies to develop highly specific genetic vaccines. The company was founded on September 10, 2007 and is headquartered in Conifer, CO.
3
| Private Company | Pharmaceuticals: Major | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Mark A. Gohr via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| University of Illinois | College/University | Undergraduate Degree | |
| The University of Colorado | College/University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
Sectorielle
| Consumer Services | 3 |
Opérationnelle
| President | 2 |
| Undergraduate Degree | 2 |
| Chief Executive Officer | 1 |
| Corporate Secretary | 1 |
Relations les plus connectées
| Insiders | |
|---|---|
| Jeffrey W. Villano | 2 |
| James J. Tufts | 2 |
| Larry A. Gelhaar | 1 |
- Bourse
- Insiders
- Mark A. Gohr
- Connexions Sociétés
